Focus: Valneva is an Austrian biotechnology company specializing in biologics manufacturing focused on infectious diseases and vaccines. The company operates as a mid-cap biotech with a pipeline concentrated in viral vaccine development.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
Stable — net +3 jobs in 30d
8 added, 5 removed. Backfill posture.
Valneva offers focused infectious disease expertise and manufacturing specialization suitable for candidates seeking vaccine/biologics development experience, but limited headcount suggests a smaller, more specialized opportunity than mid-cap peers.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Valneva
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Valneva's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles